EPA guidance on assessment of negative symptoms in schizophrenia. - EPA | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
EPA
2021
EPA guidance on assessment of negative symptoms in schizophrenia.
Document
Analyser ce document